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A B S T R A C T
Brevibacterium massiliense infection in man is rare. We report here the second case with isolation of B.
massiliense in human. This micro-organism requires specific laboratory investigations such as 16S rRNA
gene sequencing for accurate species identification. The clinical outcome was favorable.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In December 2015, a 4-year-old boy was admitted to the
pediatric neurology unit of Timone Pediatric Hospital, Marseille,
France for fever.
The patient is followed in the center of reference for metabolical
disease because of a methylmalonic acidemia (with C.844C > G
mutation homozygous in the MUT gene) diagnosed when he was
8 months old in a context of metabolic acidosis and preexisting
hypotonia, during an intercurrent illness. Because of feeding
difficulties due to his metabolical disease, a gastrostomy tube was
placed when he was 2 years old. The treatment of his metabolical
disease consist of a protein restricted diet, with hypercaloric
nutrition and antimicrobial therapy with metronidazole 3 weeks
per month to reduce propionic acid formation (a source of
intoxication in this disease) by gut flora.
Before hospitalization, he saw his general practitioner for fever,
cough and vomiting for 4 days, who prescribed cefixime orally. On
admission his physical exam shows only congestive eardrums and
a discharge of left ear without pharyngitis. Blood test included
CRP = 0.59 mg/dL, white blood cells = 9400 mL, platelets:
363,000 mL; creatine: 37 mmol/L, urea: 3.5 mmol/l, ASAT:74UI/L,
ALAT: 32UI/L, oxalemia: 0.020 mmol/l, HCO3: 22.4 mmmol/l. The
oral cefixime was stopped, and intra-auricular ofloxacin was
prescribed for 8 days. After 3 days in hospital, he returned to home* Corresponding author at: Unité de Recherche sur les Maladies Infectieuses et
Tropicales Emergentes, UM 63, UMR CNRS 7278, IRD 198, Inserm 1095, Aix-
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BACTEC; Becton Dickinson, Sparks, MD) performed on admission
was positive after 72 h of culture with Gram positive bacilli.
TheGram-positive bacillus was isolated but no phenotypic
identification was obtained by MicroFlex mass spectrometer
(Bruker Daltonics, Bremen, Germany). Molecular identification
based on 16 s rRNA gene sequence comparison was performed [6]
and showed that the isolate was Brevibacterium massiliense with
99.60% of similarity with the genbank sequence NR116479.
Susceptibility of the strain was tested using the disk diffusion
method on Mueller-Hinton agar plates incubated at 37 C for 24 h.
Our isolate was susceptible to amoxicillin, amoxicillin clavulanic
acid, cefixime, imipenem, ofloxacin and vancomycin. The mother
was contacted, and the boy had no fever and was in a good healthy
state. No more antimicrobials were prescribed.
We report here the second case of isolation with B. massiliense
in human, in blood culture. B. massiliense was isolated and this new
species was described for the first time in 2009 [8] and his draft
genome sequence was performed in 2012 [9]. The strain was
isolated from an ankle discharge obtained from a patient with open
dislocation on the left ankle and a fibula fracture [8]. Brevibacte-
rium species are Gram positive bacilli, non-spore-forming, non-
branching rods. The genus Brevibacterium consists of 50 different
species. Nine species have been isolated from human: B. casei is the
most frequent human isolate, B. epidermidis,B. otitidis, B. paucivor-
ans, B. sanguinis, B. linens, B. iodinum, B. mcbrellneri, and B.
massiliense [8,9]. Brevibacterium spp. have been isolated from dairy
product (raw milk and surface-ripened cheeses) and it is part of
normal human skin [4]. In the literature, Brevibacterium have been
isolated from human. Brevibacterium sp. have been implicated in
several infections such as peritonitis [1], bacteremia [4], boneder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
26 M. Vecten et al. / IDCases 7 (2017) 25–26infection [7,8], pericardial infection [2], endocarditis [3], brain
abscess [5]. These organisms have emerged as opportunistic
pathogens in most reported cases; patients had underlying
malignancy or immunodeficiency disease [10].
Conclusion
Phenotypic method failed in the identification of B. massiliense
only the16S rRNA gene sequencing allowed to identified the strain.
Misidentification in routine microbiology laboratory conduces to
underestimation of such relevant bacteria and may considerably
impact the diagnosis of emerging pathogens. Therefore, it is
important to sensitize microbiologists to identify this environ-
mental bacteria using the16S rRNA gene sequencing.
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